TY - JOUR
T1 - Evaluation of Effectiveness of Global COVID-19 Vaccination Campaign
AU - He, Daihai
AU - Ali, Sheikh Taslim
AU - Fan, Guihong
AU - Gao, Daozhou
AU - Song, Haitao
AU - Lou, Yijun
AU - Zhao, Shi
AU - Cowling, Benjamin J.
AU - Stone, Lewi
N1 - Funding Information:
This study was supported by the Collaborative Research Fund (grant no. HKU C7123-20G) of the Research Grants Council of Hong Kong, China. D.G. was partially supported by the National Science Foundation of Shanghai (grant no. 20ZR1440600). H.S. was partially supported by the National Natural Science Foundation of China (grant no. 12171291), the Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province (grant no. 20200001), and the Fundamental Research Program of Shanxi Province (grant no. 20210302124018). B.J.C. is supported by the AIR@innoHK program of the Innovation and Technology Commission of the Hong Kong Special Administrative Region Government.
Publisher Copyright:
© 2022 Centers for Disease Control and Prevention (CDC). All rights reserved.
PY - 2022/9
Y1 - 2022/9
N2 - To model estimated deaths averted by COVID-19 vaccines, we used state-of-the-art mathematical modeling, likelihood-based inference, and reported COVID-19 death and vaccination data. We estimated that >1.5 million deaths were averted in 12 countries. Our model can help assess effectiveness of the vaccination program, which is crucial for curbing the COVID-19 pandemic.
AB - To model estimated deaths averted by COVID-19 vaccines, we used state-of-the-art mathematical modeling, likelihood-based inference, and reported COVID-19 death and vaccination data. We estimated that >1.5 million deaths were averted in 12 countries. Our model can help assess effectiveness of the vaccination program, which is crucial for curbing the COVID-19 pandemic.
UR - http://www.scopus.com/inward/record.url?scp=85137008020&partnerID=8YFLogxK
U2 - 10.3201/eid2809.212226
DO - 10.3201/eid2809.212226
M3 - Journal article
C2 - 35914516
AN - SCOPUS:85137008020
SN - 1080-6040
VL - 28
SP - 1873
EP - 1876
JO - Emerging Infectious Diseases
JF - Emerging Infectious Diseases
IS - 9
ER -